Dr. Tin Bui, DO
NPI: 1356846265
Total Payments
$2,263
2024 Payments
$655.41
Companies
20
Transactions
59
Medicare Patients
797
Medicare Billing
$44,698
Payment Breakdown by Category
Food & Beverage$2,263 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,263 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $547.57 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $275.15 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $274.95 | 2 | $0 (2021) |
| ABBVIE INC. | $228.76 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $127.64 | 2 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $123.97 | 1 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $110.87 | 1 | $0 (2020) |
| Novo Nordisk Inc | $107.95 | 7 | $0 (2024) |
| PFIZER INC. | $88.15 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $60.54 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $655.41 | 27 | AstraZeneca Pharmaceuticals LP ($165.14) |
| 2023 | $394.65 | 19 | AstraZeneca Pharmaceuticals LP ($132.75) |
| 2022 | $139.28 | 2 | AstraZeneca Pharmaceuticals LP ($123.79) |
| 2021 | $818.89 | 8 | Biohaven Pharmaceuticals, Inc. ($275.15) |
| 2020 | $128.72 | 2 | Neurocrine Biosciences, Inc. ($110.87) |
| 2019 | $125.89 | 1 | AstraZeneca Pharmaceuticals LP ($125.89) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.72 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.36 | General |
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Biological | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Biological | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.77 | General |
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.46 | General |
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 675 | 845 | $153,880 | $36,459 |
| 2022 | 5 | 122 | 138 | $24,650 | $8,240 |
Total Patients
797
Total Services
983
Medicare Billing
$44,698
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 323 | $80,427 | $16,506 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 130 | $22,880 | $4,737 | 20.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $23,622 | $4,273 | 18.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $5,980 | $3,309 | 55.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 14 | 14 | $3,584 | $1,957 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $1,840 | $1,474 | 80.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 24 | $8,352 | $1,242 | 14.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 24 | 24 | $2,880 | $1,207 | 41.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 63 | $630.00 | $529.20 | 84.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 13 | $715.00 | $500.78 | 70.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $840.00 | $404.88 | 48.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $1,530 | $216.90 | 14.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 30 | $600.00 | $102.30 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 46 | $11,454 | $3,407 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 51 | $8,976 | $2,654 | 29.6% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 15 | 15 | $3,840 | $2,097 | 54.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 14 | $140.00 | $41.16 | 29.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 12 | $240.00 | $40.92 | 17.1% |
About Dr. Tin Bui, DO
Dr. Tin Bui, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in East Norriton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1356846265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tin Bui, DO has received a total of $2,263 in payments from pharmaceutical and medical device companies, with $655.41 received in 2024. These payments were reported across 59 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,263).
As a Medicare-enrolled provider, Bui has provided services to 797 Medicare beneficiaries, totaling 983 services with total Medicare billing of $44,698. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location East Norriton, PA
- Active Since 03/24/2018
- Last Updated 06/14/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356846265
Products in Payments
- NURTEC ODT (Drug) $275.15
- XARELTO (Drug) $274.95
- FARXIGA (Drug) $271.30
- VRAYLAR (Drug) $179.68
- AIRSUPRA (Drug) $134.61
- NUZYRA (Drug) $123.97
- BEXSERO (Biological) $112.44
- INGREZZA (Drug) $110.87
- PREVNAR 20 (Biological) $67.65
- Dexcom G6 Transmitter (Medical Supply) $53.50
- XIFAXAN (Drug) $44.32
- Veozah (Drug) $43.70
- Cologuard Collection Kit (Device) $34.40
- Ozempic (Drug) $29.19
- MOUNJARO (Drug) $28.65
- INTELLIS ADAPTIVESTIM (Device) $24.44
- LEQVIO (Drug) $23.31
- COMIRNATY (Biological) $20.50
- GLYCATE (Drug) $19.88
- Otezla (Drug) $18.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in East Norriton
Lorin Berman, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $2,838
Student in an Organized Health Care Education/Training Program $2,838
Vincent Nguyen, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,793
Student in an Organized Health Care Education/Training Program $2,793
Dr. James Wright, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $1,292
Student in an Organized Health Care Education/Training Program $1,292
Stephen Capecci, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $568.24
Student in an Organized Health Care Education/Training Program $568.24
Marilyn Le, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $297.07
Student in an Organized Health Care Education/Training Program $297.07
Ann Mclaughlan, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $286.72
Student in an Organized Health Care Education/Training Program $286.72